Bioequivalence and Bioavailability Forum • ICH M13A (IR BE)

ICH M13A (IR BE) [BE/BA News]

posted by dshah – India/United Kingdom, 2023-01-17 13:02 (456 d 12:45 ago) – Posting: # 23426
Views: 3,196

Hi Rasha_J!

Below information might be helpful:

"stakeholders from ICH Member countries/regions are encouraged to submit their comments to their respective Regulatory Authorities, noting the deadline for comments indicated beneath each draft Guideline.

Stakeholders can also provide their comments by e-mailing the ICH Secretariat at [email protected]. For this purpose please make sure to use the ICH Template in Excel format. https://admin.ich.org/sites/default/files/2020-12/ICH_PublicConsultationComments_Template_Stakeholders_2020_1014.xlsx

Please note that comments provided to the ICH Secretariat will be shared with the appointed participants of the relevant ICH Working Group responsible for the development of draft documents submitted to consultation."

Regrards,
Divyen

Complete thread:

ICH M13A (IR BE) Helmut 2022-12-23 09:05
- ICH M13A (IR BE) Rasha_J 2023-01-16 05:27
  - ICH M13A (IR BE) Helmut 2023-01-16 09:19
  - ICH M13A (IR BE) SMA 2023-01-17 09:30
  - ICH M13A (IR BE)dshah 2023-01-17 12:02
  - ICH M13A (IR BE) Rasha_J 2023-01-18 09:53
  - ICH M13A (IR BE) : FDA web site Ohlbe 2023-02-01 14:14
    - Knowledge is power… Helmut 2023-02-09 12:34
- ICH M13A (IR BE): EMA consultation SMA 2023-02-08 09:10
  - ICH M13A (IR BE): EMA comments received Helmut 2023-09-18 10:54